Early preclinical and clinical data have shown that selinexor has broad activity against multiple hematologic malignancies and notable antimyeloma activity.
from Latest articles from Cancer Therapy Advisor Hematologic Cancers https://ift.tt/2LfV3P9
from Latest articles from Cancer Therapy Advisor Hematologic Cancers https://ift.tt/2LfV3P9